gms | German Medical Science

48th Meeting of the Particle Therapy Co-Operative Group

Particle Therapy Co-Operative Group (PTCOG)

28.09. - 03.10.2009, Heidelberg

Proton Therapy for Lung Cancer at LLUMC

Meeting Abstract

Search Medline for

  • D. Bush - Radiation Medicine, Loma Linda University Medical Center, Loma Linda, USA

PTCOG 48. Meeting of the Particle Therapy Co-Operative Group. Heidelberg, 28.09.-03.10.2009. Düsseldorf: German Medical Science GMS Publishing House; 2009. Doc09ptcog027

DOI: 10.3205/09ptcog027, URN: urn:nbn:de:0183-09ptcog0275

Published: September 24, 2009

© 2009 Bush.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Researchers at LLUMC have had interest in using proton therapy for the treatment of non-small cell lung cancer since the center began clinical operations. This presentation will review the rational for proton beam therapy in lung cancer and review dosimetric issues unique to treatment of pulmonary tumors with particle beams. Results from two ongoing clinical trials at LLUMC will be presented. These trials include phase II trials in non-small cell lung cancer for subjects with stage I, medically inoperable disease and a second study for stage III patients that combines chemotherapy with proton therapy. Treatment outcomes including suvival, recurrence patterns and treatment toxicity will be discussed.